Physician profile
Theodore Roberto
NPI 1730417130
$807.83
in general payments reported to CMS, 2019-2025
14 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $67.40 · 2021: $30.43 · 2022: $24.36 · 2023: $94.08 · 2024: $141 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $308.97 | 2023-2025 | Prostep Mica, Citrefix, Easyfuse |
| Wright Medical Technology, INC. | $167.08 | 2019-2020 | |
| Smith+Nephew, INC. | $63.54 | 2019-2023 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $45.00 | 2019 | |
| Organogenesis INC. | $32.96 | 2019-2021 | |
| Melinta Therapeutics, LLC | $28.21 | 2019 | |
| Horizon Therapeutics Plc | $27.74 | 2019-2020 | |
| Polarityte, INC. | $26.24 | 2019 | |
| Reapplix INC. | $24.36 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.92 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $19.88 | 2023 | |
| Celularity INC. | $17.06 | 2020 | |
| Kci USA, INC. | $14.92 | 2020 | |
| Paragon 28, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Roberto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.